Pharma Stocks Surge Amid Market Weakness, Dr Reddy's Leads Gains
Pharma stocks buck market weakness as Dr Reddy's gains
The Economic Times
Image: The Economic Times
On Thursday, pharmaceutical stocks outperformed the broader market, primarily driven by a 9.4% increase in Dr Reddy's Laboratories following positive sentiment regarding the approval of its diabetes drug, Semaglutide, in Canada. The Nifty Pharma Index rose 2.4%, contrasting with a 0.8% decline in the benchmark Nifty.
- 01Dr Reddy's Laboratories experienced a 9.4% surge, marking its highest single-day gain since September 2017.
- 02The Nifty Pharma Index rose 2.4%, while the benchmark Nifty fell 0.8%.
- 03Expectations surrounding the approval of Semaglutide in Canada boosted investor sentiment.
- 04Other pharma companies like Piramal Pharma and Cipla also saw significant gains.
- 05Market volatility led fund managers to shift towards defensive stocks amid geopolitical uncertainties.
Advertisement
In-Article Ad
Pharmaceutical stocks showed resilience in a declining market on Thursday, with Dr Reddy's Laboratories leading the charge after a 9.4% increase, the highest since September 2017. This surge was attributed to growing optimism about the approval of its diabetes drug, Semaglutide, in Canada, with a target action date approaching in May. The Nifty Pharma Index gained 2.4%, contrasting with a 0.8% drop in the benchmark Nifty index, as 16 out of 20 stocks in the pharma sector advanced. Other companies in the Semaglutide value chain, such as OneSource Specialty Pharma and Shaily Engineering Plastics, also experienced substantial gains of 10.8% and 14.1%, respectively. Analysts suggest that the increasing popularity of pharma stocks is due to their defensive nature amid a volatile market environment, influenced by geopolitical tensions and fluctuating oil prices.
Advertisement
In-Article Ad
The performance of pharmaceutical stocks indicates a shift in investor sentiment towards defensive sectors amid broader market uncertainties, which could influence future investment strategies.
Advertisement
In-Article Ad
Reader Poll
Do you think pharmaceutical stocks are a safer investment during market volatility?
Connecting to poll...
Read the original article
Visit the source for the complete story.